Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in HER2-Low Breast Cancer

Research To Practice | Oncology Videos · Jul 7, 2022 · 35m

Featuring an interview with Dr Adam Brufsky, including the following topics:

Trastuzumab deruxtecan (T-DXd) for HER2-low breast cancer; recently presented findings from the DESTINY-BREAST04 trial (0:00)

Impact of heterogeneous disease on the detection of HER2-low expression in patients with breast cancer (7:48)

Case: A woman with low-volume, asymptomatic and nonvisceral ER-positive, HER2-low breast cancer (13:16)

Case: A woman with high-volume, symptomatic and visceral HER2-low breast cancer; treating ER-negative, HER2-low disease (18:44)

Toxicities associated with T-DXd (25:25)

Ongoing…